Safety of adalimumab in Crohn's disease during pregnancy: Case report and review of the literature
Matthias Jürgens MD
Department of Medicine II, Grosshadern, Ludwig-Maximilians-University, Munich, Germany
Search for more papers by this authorStephan Brand MD
Department of Medicine II, Grosshadern, Ludwig-Maximilians-University, Munich, Germany
Search for more papers by this authorLevent Filik MD
Department of Gastroenterology, Ankara Research Hospital, Ankara, Turkey
Search for more papers by this authorChristoph Hübener MD
Department of Gynecology and Obstetrics, Grosshadern, Ludwig-Maximilians-University, Munich, Germany
Search for more papers by this authorUwe Hasbargen MD
Department of Gynecology and Obstetrics, Grosshadern, Ludwig-Maximilians-University, Munich, Germany
Search for more papers by this authorFlorian Beigel MD
Department of Medicine II, Grosshadern, Ludwig-Maximilians-University, Munich, Germany
Search for more papers by this authorCornelia Tillack MD
Department of Medicine II, Grosshadern, Ludwig-Maximilians-University, Munich, Germany
Search for more papers by this authorBurkhard Göke MD
Department of Medicine II, Grosshadern, Ludwig-Maximilians-University, Munich, Germany
Search for more papers by this authorThomas Ochsenkühn MD
Department of Medicine II, Grosshadern, Ludwig-Maximilians-University, Munich, Germany
Search for more papers by this authorJulia Seiderer MD
Department of Medicine II, Grosshadern, Ludwig-Maximilians-University, Munich, Germany
Search for more papers by this authorMatthias Jürgens MD
Department of Medicine II, Grosshadern, Ludwig-Maximilians-University, Munich, Germany
Search for more papers by this authorStephan Brand MD
Department of Medicine II, Grosshadern, Ludwig-Maximilians-University, Munich, Germany
Search for more papers by this authorLevent Filik MD
Department of Gastroenterology, Ankara Research Hospital, Ankara, Turkey
Search for more papers by this authorChristoph Hübener MD
Department of Gynecology and Obstetrics, Grosshadern, Ludwig-Maximilians-University, Munich, Germany
Search for more papers by this authorUwe Hasbargen MD
Department of Gynecology and Obstetrics, Grosshadern, Ludwig-Maximilians-University, Munich, Germany
Search for more papers by this authorFlorian Beigel MD
Department of Medicine II, Grosshadern, Ludwig-Maximilians-University, Munich, Germany
Search for more papers by this authorCornelia Tillack MD
Department of Medicine II, Grosshadern, Ludwig-Maximilians-University, Munich, Germany
Search for more papers by this authorBurkhard Göke MD
Department of Medicine II, Grosshadern, Ludwig-Maximilians-University, Munich, Germany
Search for more papers by this authorThomas Ochsenkühn MD
Department of Medicine II, Grosshadern, Ludwig-Maximilians-University, Munich, Germany
Search for more papers by this authorJulia Seiderer MD
Department of Medicine II, Grosshadern, Ludwig-Maximilians-University, Munich, Germany
Search for more papers by this author
REFERENCES
- 1 Hanauer SB, Sandborn WJ, Rutgeerts P, et al. Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial. Gastroenterology. 2006; 130: 323–333.
- 2 Podolsky DK. Inflammatory bowel disease. N Engl J Med. 2002; 347: 417–429.
- 3 Schnitzler F, Fidder HH, Ferrante M, et al. Intentional treatment with infliximab during pregnancy in women with inflammatory bowel disease. Gastroenterology. 2007; 132: A144.
- 4 Angelucci E, Cocco A, Viscido A, et al. Safe use of infliximab for the treatment of fistulizing Crohn's disease during pregnancy within 3 months of conception. Inflamm Bowel Dis. 2008; 14: 435–436.
- 5 Carter JD, Ladhani A, Ricca LR, et al. A safety assessment of tumor necrosis factor antagonists during pregnancy: a review of the Food and Drug Administration database. J Rheumatol. 2009; 36: 635–641.
- 6 Giroir BP, Peppel K, Silva M, et al. The biosynthesis of tumor necrosis factor during pregnancy: studies with a CAT reporter transgene and TNF inhibitors. Eur Cytokine Netw. 1992; 3: 533–538.
- 7 Simister NE. Placental transport of immunoglobulin G. Vaccine. 2003; 21: 3365–3369.